Livzon Pharmaceutical Group (HK:1513) has released an update.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Livzon Pharmaceutical Group has announced a change in leadership with the resignation of Mr. Yang Liang as Company Secretary and Authorized Representative, effective December 31, 2024. He will be succeeded by Ms. Liu Ning, whose extensive experience in the financial sector positions her well for this role. This transition is expected to maintain the company’s smooth operation and compliance with Hong Kong’s listing regulations.
For further insights into HK:1513 stock, check out TipRanks’ Stock Analysis page.